Maximal and Submaximal Exercise Testing in Heart Failure

Although reduced exercise capacity is the main complaint of patients with congestive heart failure (CHF), the best method to measure it remains controversial. Peak VO2, obtained using maximal exercise testing, is the most accurate measure of maximal functional capacity. It is related to peak exercis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular pharmacology 1998, Vol.32 Suppl 1 (Supplement 1), p.S36-S45
Hauptverfasser: Metra, Marco, Nodari, Savina, Raccagni, Domenica, Garbellini, Maria, Boldi, Emiliano, Bontempi, Luca, Gaiti, Monica, Cas, Livio Dei
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S45
container_issue Supplement 1
container_start_page S36
container_title Journal of cardiovascular pharmacology
container_volume 32 Suppl 1
creator Metra, Marco
Nodari, Savina
Raccagni, Domenica
Garbellini, Maria
Boldi, Emiliano
Bontempi, Luca
Gaiti, Monica
Cas, Livio Dei
description Although reduced exercise capacity is the main complaint of patients with congestive heart failure (CHF), the best method to measure it remains controversial. Peak VO2, obtained using maximal exercise testing, is the most accurate measure of maximal functional capacity. It is related to peak exercise cardiac output and is one of the most important independent variables for the prognostic assessment of patients with CHF. It has, however, a low sensitivity for measurement of changes induced by therapy and is poorly related to everyday physical activity, patient symptoms, and quality of life. The anerobic threshold may also be regarded as a parameter of maximal functional capacity. Its value is mainly indirect, because it shows that the patient is performing a maximal effort limited by the cardiovascular system. The VO2 kinetics at the start and at the end of exercise are probably more related to patient symptoms, but it is unresolved which protocols and parameters might best be used to study this aspect of exercise performance. Duration of a submaximal exercise at a constant work rate and the distance walked during a 6-min walking test are gaining wide popularity as parameters of submaximal performance. However, when these exams are carried out up to exhaustion in patients with severe functional limitation, they may involve attainment of the anerobic threshold and therefore their clinical meaning may be similar to the one of a maximal exercise test. Moreover, tests based on the assessment of submaximal exercise capacity have been useful for assessment of therapy in single-center trials but have been often inadequate in multicenter trials.
doi_str_mv 10.1097/00005344-199806321-00007
format Article
fullrecord <record><control><sourceid>wolterskluwer_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00005344_199806321_00007</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00005344-199806321-00007</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1997-c45f4b77fcbde224ace3e6b022939d6bf602a8e6c1c32ec0aaa5d3fb9185db373</originalsourceid><addsrcrecordid>eNp1kM1OwzAQhC0EEqHwDn4Bw_ondnJEVUuRijhQzpbtbGggTZGdqOXtaWjhxlxWM9KsRh8hlMMth9LcwUG5VIrxsixAS8HZGJkzkvFcSqZAyHOSAdfAhFL6klyl9A7AVW50Roont282rqWuq-jL4DcnO9tjDE1CusLUN90bbTq6QBd7OndNO0S8Jhe1axPenO6EvM5nq-mCLZ8fHqf3SxYOgwwLKq-VN6YOvkIhlAsoUXsQopRlpX2tQbgCdeBBCgzgnMsrWfuSF3nlpZETUhz_hrhNKWJtP-NhYfyyHOxIwP4SsH8EfqKxqo7V3bbtMaaPdthhtGt0bb-2_4GT34kLXhI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Maximal and Submaximal Exercise Testing in Heart Failure</title><source>Journals@Ovid Ovid Autoload</source><source>Journals@OVID</source><source>EZB Electronic Journals Library</source><creator>Metra, Marco ; Nodari, Savina ; Raccagni, Domenica ; Garbellini, Maria ; Boldi, Emiliano ; Bontempi, Luca ; Gaiti, Monica ; Cas, Livio Dei</creator><creatorcontrib>Metra, Marco ; Nodari, Savina ; Raccagni, Domenica ; Garbellini, Maria ; Boldi, Emiliano ; Bontempi, Luca ; Gaiti, Monica ; Cas, Livio Dei</creatorcontrib><description>Although reduced exercise capacity is the main complaint of patients with congestive heart failure (CHF), the best method to measure it remains controversial. Peak VO2, obtained using maximal exercise testing, is the most accurate measure of maximal functional capacity. It is related to peak exercise cardiac output and is one of the most important independent variables for the prognostic assessment of patients with CHF. It has, however, a low sensitivity for measurement of changes induced by therapy and is poorly related to everyday physical activity, patient symptoms, and quality of life. The anerobic threshold may also be regarded as a parameter of maximal functional capacity. Its value is mainly indirect, because it shows that the patient is performing a maximal effort limited by the cardiovascular system. The VO2 kinetics at the start and at the end of exercise are probably more related to patient symptoms, but it is unresolved which protocols and parameters might best be used to study this aspect of exercise performance. Duration of a submaximal exercise at a constant work rate and the distance walked during a 6-min walking test are gaining wide popularity as parameters of submaximal performance. However, when these exams are carried out up to exhaustion in patients with severe functional limitation, they may involve attainment of the anerobic threshold and therefore their clinical meaning may be similar to the one of a maximal exercise test. Moreover, tests based on the assessment of submaximal exercise capacity have been useful for assessment of therapy in single-center trials but have been often inadequate in multicenter trials.</description><identifier>ISSN: 0160-2446</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/00005344-199806321-00007</identifier><language>eng</language><publisher>Lippincott-Raven Publishers</publisher><ispartof>Journal of cardiovascular pharmacology, 1998, Vol.32 Suppl 1 (Supplement 1), p.S36-S45</ispartof><rights>Lippincott-Raven Publishers.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1997-c45f4b77fcbde224ace3e6b022939d6bf602a8e6c1c32ec0aaa5d3fb9185db373</citedby><cites>FETCH-LOGICAL-c1997-c45f4b77fcbde224ace3e6b022939d6bf602a8e6c1c32ec0aaa5d3fb9185db373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00005344-199806321-00007$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00005344-199806321-00007$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,780,784,4024,4609,27923,27924,27925,64566,65333</link.rule.ids></links><search><creatorcontrib>Metra, Marco</creatorcontrib><creatorcontrib>Nodari, Savina</creatorcontrib><creatorcontrib>Raccagni, Domenica</creatorcontrib><creatorcontrib>Garbellini, Maria</creatorcontrib><creatorcontrib>Boldi, Emiliano</creatorcontrib><creatorcontrib>Bontempi, Luca</creatorcontrib><creatorcontrib>Gaiti, Monica</creatorcontrib><creatorcontrib>Cas, Livio Dei</creatorcontrib><title>Maximal and Submaximal Exercise Testing in Heart Failure</title><title>Journal of cardiovascular pharmacology</title><description>Although reduced exercise capacity is the main complaint of patients with congestive heart failure (CHF), the best method to measure it remains controversial. Peak VO2, obtained using maximal exercise testing, is the most accurate measure of maximal functional capacity. It is related to peak exercise cardiac output and is one of the most important independent variables for the prognostic assessment of patients with CHF. It has, however, a low sensitivity for measurement of changes induced by therapy and is poorly related to everyday physical activity, patient symptoms, and quality of life. The anerobic threshold may also be regarded as a parameter of maximal functional capacity. Its value is mainly indirect, because it shows that the patient is performing a maximal effort limited by the cardiovascular system. The VO2 kinetics at the start and at the end of exercise are probably more related to patient symptoms, but it is unresolved which protocols and parameters might best be used to study this aspect of exercise performance. Duration of a submaximal exercise at a constant work rate and the distance walked during a 6-min walking test are gaining wide popularity as parameters of submaximal performance. However, when these exams are carried out up to exhaustion in patients with severe functional limitation, they may involve attainment of the anerobic threshold and therefore their clinical meaning may be similar to the one of a maximal exercise test. Moreover, tests based on the assessment of submaximal exercise capacity have been useful for assessment of therapy in single-center trials but have been often inadequate in multicenter trials.</description><issn>0160-2446</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNp1kM1OwzAQhC0EEqHwDn4Bw_ondnJEVUuRijhQzpbtbGggTZGdqOXtaWjhxlxWM9KsRh8hlMMth9LcwUG5VIrxsixAS8HZGJkzkvFcSqZAyHOSAdfAhFL6klyl9A7AVW50Roont282rqWuq-jL4DcnO9tjDE1CusLUN90bbTq6QBd7OndNO0S8Jhe1axPenO6EvM5nq-mCLZ8fHqf3SxYOgwwLKq-VN6YOvkIhlAsoUXsQopRlpX2tQbgCdeBBCgzgnMsrWfuSF3nlpZETUhz_hrhNKWJtP-NhYfyyHOxIwP4SsH8EfqKxqo7V3bbtMaaPdthhtGt0bb-2_4GT34kLXhI</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>Metra, Marco</creator><creator>Nodari, Savina</creator><creator>Raccagni, Domenica</creator><creator>Garbellini, Maria</creator><creator>Boldi, Emiliano</creator><creator>Bontempi, Luca</creator><creator>Gaiti, Monica</creator><creator>Cas, Livio Dei</creator><general>Lippincott-Raven Publishers</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1998</creationdate><title>Maximal and Submaximal Exercise Testing in Heart Failure</title><author>Metra, Marco ; Nodari, Savina ; Raccagni, Domenica ; Garbellini, Maria ; Boldi, Emiliano ; Bontempi, Luca ; Gaiti, Monica ; Cas, Livio Dei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1997-c45f4b77fcbde224ace3e6b022939d6bf602a8e6c1c32ec0aaa5d3fb9185db373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Metra, Marco</creatorcontrib><creatorcontrib>Nodari, Savina</creatorcontrib><creatorcontrib>Raccagni, Domenica</creatorcontrib><creatorcontrib>Garbellini, Maria</creatorcontrib><creatorcontrib>Boldi, Emiliano</creatorcontrib><creatorcontrib>Bontempi, Luca</creatorcontrib><creatorcontrib>Gaiti, Monica</creatorcontrib><creatorcontrib>Cas, Livio Dei</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Metra, Marco</au><au>Nodari, Savina</au><au>Raccagni, Domenica</au><au>Garbellini, Maria</au><au>Boldi, Emiliano</au><au>Bontempi, Luca</au><au>Gaiti, Monica</au><au>Cas, Livio Dei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Maximal and Submaximal Exercise Testing in Heart Failure</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><date>1998</date><risdate>1998</risdate><volume>32 Suppl 1</volume><issue>Supplement 1</issue><spage>S36</spage><epage>S45</epage><pages>S36-S45</pages><issn>0160-2446</issn><eissn>1533-4023</eissn><abstract>Although reduced exercise capacity is the main complaint of patients with congestive heart failure (CHF), the best method to measure it remains controversial. Peak VO2, obtained using maximal exercise testing, is the most accurate measure of maximal functional capacity. It is related to peak exercise cardiac output and is one of the most important independent variables for the prognostic assessment of patients with CHF. It has, however, a low sensitivity for measurement of changes induced by therapy and is poorly related to everyday physical activity, patient symptoms, and quality of life. The anerobic threshold may also be regarded as a parameter of maximal functional capacity. Its value is mainly indirect, because it shows that the patient is performing a maximal effort limited by the cardiovascular system. The VO2 kinetics at the start and at the end of exercise are probably more related to patient symptoms, but it is unresolved which protocols and parameters might best be used to study this aspect of exercise performance. Duration of a submaximal exercise at a constant work rate and the distance walked during a 6-min walking test are gaining wide popularity as parameters of submaximal performance. However, when these exams are carried out up to exhaustion in patients with severe functional limitation, they may involve attainment of the anerobic threshold and therefore their clinical meaning may be similar to the one of a maximal exercise test. Moreover, tests based on the assessment of submaximal exercise capacity have been useful for assessment of therapy in single-center trials but have been often inadequate in multicenter trials.</abstract><pub>Lippincott-Raven Publishers</pub><doi>10.1097/00005344-199806321-00007</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0160-2446
ispartof Journal of cardiovascular pharmacology, 1998, Vol.32 Suppl 1 (Supplement 1), p.S36-S45
issn 0160-2446
1533-4023
language eng
recordid cdi_crossref_primary_10_1097_00005344_199806321_00007
source Journals@Ovid Ovid Autoload; Journals@OVID; EZB Electronic Journals Library
title Maximal and Submaximal Exercise Testing in Heart Failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A16%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Maximal%20and%20Submaximal%20Exercise%20Testing%20in%20Heart%20Failure&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Metra,%20Marco&rft.date=1998&rft.volume=32%20Suppl%201&rft.issue=Supplement%201&rft.spage=S36&rft.epage=S45&rft.pages=S36-S45&rft.issn=0160-2446&rft.eissn=1533-4023&rft_id=info:doi/10.1097/00005344-199806321-00007&rft_dat=%3Cwolterskluwer_cross%3E00005344-199806321-00007%3C/wolterskluwer_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true